Pia Kuster

Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma

Friederike Hoffmann, G. Kristiansen, Jörn Dietrich, 2020, Clinical Epigenetics.

Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma

Friederike Hoffmann, G. Kristiansen, Jörn Dietrich, 2020, EBioMedicine.

DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy

Friederike Hoffmann, Jörn Dietrich, J. Landsberg, 2022, Clinical Epigenetics.

DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy

Friederike Hoffmann, Jörn Dietrich, J. Landsberg, 2022, Clinical epigenetics.

CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma

Friederike Hoffmann, J. Landsberg, D. Dietrich, 2023, Clinical Epigenetics.

ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade

Friederike Hoffmann, G. Kristiansen, Jörn Dietrich, 2023, Biomarker Research.